CIK 0001743881 · Large accelerated filer
BridgeBio Pharma, Inc.
Sign in to watch- Ticker
- BBIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (650) 391-9740
- Business address
- 3160 PORTER DR., SUITE 250, PALO ALTO, CA, 94304
- Former names
- BridgeBio Pharma LLC
- 4 Grant or award President and CFO acquired 59,041 shares (grant or award)
- 4 Grant or award Chief Accounting Officer acquired 14,170 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Planned sale Chief Executive Officer sold 80,000 shares at an average $68.76 ($5,501,068)
- 144 Insider Sale of Securities
- 4 Planned sale Director sold 8,671 shares at $72.00 ($624,312)
- 144 Insider Sale of Securities
- 4 Planned sale Director sold 64,921 shares at $64.87 ($4,211,302)
- 144 Insider Sale of Securities
- 4 Planned sale Director sold 25,484 shares at an average $67.41 ($1,717,781)
- 144 Insider Sale of Securities
- 4 Planned sale Chief Accounting Officer sold 2,000 shares at $66.00 ($132,000)
- 10-K Report Annual Report
- 8-K Event Results of operations
- 4 Planned sale Chief Executive Officer sold 28,053 shares at an average $71.39 ($2,002,717)
- 144 Insider Sale of Securities
- 4 Shares withheld for taxes Chief Executive Officer gave up 30,970 shares (to pay taxes)
- 4 Planned sale Chief Accounting Officer sold 510 shares at $74.31 ($37,898)
- 4 Planned sale President and CFO sold 13,600 shares at an average $74.72 ($1,016,147)
- 4 Planned sale Director sold 10,000 shares at an average $75.46 ($754,557)
Page 5 of 42 · 834 filings